Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis

Main Article Content

Kristian Reich
Mark Lebwohl
Carle Paul
Mads Ropke
Monika Rosen
Klaus Hansen


psoriasis, brodalumab, clinical trial


Abstract not available.


This study was supported by Amgen/AstraZeneca. This poster was sponsored b y LEO Pharma.

Most read articles by the same author(s)

<< < 4 5 6 7 8 9 10 11 12 13 > >>